Skip to main content
NOVT
NASDAQ Life Sciences

Novanta Q2 Revenue Jumps 10%, Raises Full-Year Outlook on Riverpoint Deal

Tom Rudovsky · Reported by BusinessWire
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Positive
Importance info
8
Price
$153.12
Mkt Cap
$5.453B
52W Low
$98.27
52W High
$171.85
52W Position info
56% above low
Off High info
11% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

NOVT sits 56% above its 52-week low of $98.27.

Summary

Novanta delivered a strong Q2 with revenue up 10.3% to $265.8M and adjusted EPS of $0.89, beating expectations. Organic growth hit 9.3%, the best since early 2023. The recently closed $1.2B Riverpoint Medical acquisition is now factored into guidance, pushing full-year revenue to $1.13-1.14B and adjusted EPS to $3.68-3.74. Riverpoint doubles the recurring medical consumables business to ~25% of sales and lifts medical exposure to ~60% of revenue. Q3 guidance calls for revenue of $300-304M and adjusted EPS of $0.95-1.00, reflecting immediate accretion. This follows the June 9 acquisition announcement and the July 27 deal close, confirming the strategic shift toward higher-margin medical markets.

Updates

  1. · SEC 10-Q — The 10-Q reports Q2 net income of $12.5M, or $0.30 diluted EPS, and six-month revenue of $523.5M.

At the time of this announcement, NOVT was trading at $153.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $98.27 to $171.85. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

NOVT - Latest Insights

NOVT
Nov 09, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $144.00
Real-time Price: $102.18 info
Change: -$41.82 (-29%) info
Market Cap: $3.857B info
NOVT
Nov 09, 2026, 4:50 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $102.18 info
Change: -$43.82 (-30%) info
Market Cap: $3.857B info
NOVT
Nov 09, 2026, 4:45 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $102.18 info
Change: -$43.82 (-30%) info
Market Cap: $3.857B info
NOVT
Oct 02, 2026, 4:30 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $149.27
Real-time Price: $102.18 info
Change: -$47.09 (-32%) info
Market Cap: $3.857B info
NOVT
Aug 05, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $158.00
Real-time Price: $102.18 info
Change: -$55.82 (-35%) info
Market Cap: $3.857B info